source Post navigation Can This Metabolic Disease Pioneer Deliver Strong Q4 Results? Fractyl Health Reports March 3 – StockTitan Nektar Therapeutics Partners With TrialNet to Test Rezpegaldesleukin in Type 1 Diabetes – Marketscreener.com